Paul A. Northcott

67.4k total citations · 3 hit papers
120 papers, 8.6k citations indexed

About

Paul A. Northcott is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Paul A. Northcott has authored 120 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 63 papers in Genetics and 30 papers in Cancer Research. Recurrent topics in Paul A. Northcott's work include Glioma Diagnosis and Treatment (63 papers), Hedgehog Signaling Pathway Studies (39 papers) and Epigenetics and DNA Methylation (32 papers). Paul A. Northcott is often cited by papers focused on Glioma Diagnosis and Treatment (63 papers), Hedgehog Signaling Pathway Studies (39 papers) and Epigenetics and DNA Methylation (32 papers). Paul A. Northcott collaborates with scholars based in United States, Canada and Germany. Paul A. Northcott's co-authors include Michael D. Taylor, Stefan M. Pfister, Andrey Korshunov, Steven C. Clifford, Charles G. Eberhart, James T. Rutka, Scott L. Pomeroy, Marcel Kool, Peter Lichter and Marc Remke and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Paul A. Northcott

116 papers receiving 8.5k citations

Hit Papers

Molecular subgroups of medulloblastoma: the current conse... 2010 2026 2015 2020 2011 2010 2019 400 800 1.2k

Peers

Paul A. Northcott
Ken Aldape United States
Gene Hung United States
Marc Remke Germany
Antonio Iavarone United States
Genglin Jin United States
Do‐Hyun Nam South Korea
Ken Aldape United States
Paul A. Northcott
Citations per year, relative to Paul A. Northcott Paul A. Northcott (= 1×) peers Ken Aldape

Countries citing papers authored by Paul A. Northcott

Since Specialization
Citations

This map shows the geographic impact of Paul A. Northcott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Northcott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Northcott more than expected).

Fields of papers citing papers by Paul A. Northcott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Northcott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Northcott. The network helps show where Paul A. Northcott may publish in the future.

Co-authorship network of co-authors of Paul A. Northcott

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Northcott. A scholar is included among the top collaborators of Paul A. Northcott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Northcott. Paul A. Northcott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Christin, Sarah L. Cohen, Brian Gudenas, et al.. (2024). PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression. Scientific Reports. 14(1). 16074–16074. 5 indexed citations
2.
Tao, Ran, et al.. (2024). Arrested development: the dysfunctional life history of medulloblastoma. Genes & Development. 39(1-2). 4–17. 1 indexed citations
3.
Tran, Quynh T., Tong Lin, Ruth Tatevossian, et al.. (2024). Comparison of DNA methylation based classification models for precision diagnostics of central nervous system tumors. npj Precision Oncology. 8(1). 218–218. 4 indexed citations
4.
Pribnow, Allison, Barbara Jonchère, Jingjing Liu, et al.. (2022). Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma. Molecular Cancer Therapeutics. 21(8). 1306–1317. 5 indexed citations
5.
Inoue, Akira, Laura J. Janke, Brian Gudenas, et al.. (2021). A genetic mouse model with postnatal Nf1 and p53 loss recapitulates the histology and transcriptome of human malignant peripheral nerve sheath tumor. Neuro-Oncology Advances. 3(1). vdab129–vdab129. 5 indexed citations
6.
Leary, Sarah, Lindsay Kilburn, J. Russell Geyer, et al.. (2021). Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026). Neuro-Oncology. 24(7). 1178–1190. 21 indexed citations
7.
Ramaswamy, Vijay, Marc Remke, David Shih, et al.. (2014). Duration of the pre‐diagnostic interval in medulloblastoma is subgroup dependent. Pediatric Blood & Cancer. 61(7). 1190–1194. 33 indexed citations
8.
Markant, Shirley L., Lourdes Adriana Esparza, Kelly L. Barton, et al.. (2013). Targeting Sonic Hedgehog-Associated Medulloblastoma through Inhibition of Aurora and Polo-like Kinases. Cancer Research. 73(20). 6310–6322. 46 indexed citations
9.
Dey, Joyoti, Adrian M. Dubuc, Kyle D. Pedro, et al.. (2013). MyoD Is a Tumor Suppressor Gene in Medulloblastoma. Cancer Research. 73(22). 6828–6837. 23 indexed citations
10.
Mumert, Michael L., Adrian M. Dubuc, Xiaochong Wu, et al.. (2012). Functional Genomics Identifies Drivers of Medulloblastoma Dissemination. Cancer Research. 72(19). 4944–4953. 38 indexed citations
11.
Sengupta, Rajarshi, Adrian M. Dubuc, Stacey Ward, et al.. (2011). CXCR4 Activation Defines a New Subgroup of Sonic Hedgehog–Driven Medulloblastoma. Cancer Research. 72(1). 122–132. 48 indexed citations
12.
Remke, Marc, Thomas Hielscher, Paul A. Northcott, et al.. (2011). Adult Medulloblastoma Comprises Three Major Molecular Variants. Journal of Clinical Oncology. 29(19). 2717–2723. 160 indexed citations
13.
Northcott, Paul A., Andrey Korshunov, Hendrik Witt, et al.. (2010). Medulloblastoma Comprises Four Distinct Molecular Variants. Journal of Clinical Oncology. 29(11). 1408–1414. 886 indexed citations breakdown →
14.
Zhou, Limei, Daniel Picard, Young‐Shin Ra, et al.. (2010). Silencing of Thrombospondin-1 Is Critical for Myc-Induced Metastatic Phenotypes in Medulloblastoma. Cancer Research. 70(20). 8199–8210. 47 indexed citations
15.
Milde, Till, Ina Oehme, Andrey Korshunov, et al.. (2010). HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth. Clinical Cancer Research. 16(12). 3240–3252. 158 indexed citations
16.
Traenka, Christopher, Marc Remke, Andrey Korshunov, et al.. (2010). Role of LIM and SH3 Protein 1 (LASP1) in the Metastatic Dissemination of Medulloblastoma. Cancer Research. 70(20). 8003–8014. 55 indexed citations
17.
Bhatia, Bobby, Paul A. Northcott, Dolores Hambardzumyan, et al.. (2009). Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma: Separate Regulation of Mammalian Target of Rapamycin Activity and p27Kip1 Localization. Cancer Research. 69(18). 7224–7234. 34 indexed citations
18.
Northcott, Paul A., Africa Fernández-L, John P. Hagan, et al.. (2009). The miR-17/92 Polycistron Is Up-regulated in Sonic Hedgehog–Driven Medulloblastomas and Induced by N-myc in Sonic Hedgehog–Treated Cerebellar Neural Precursors. Cancer Research. 69(8). 3249–3255. 227 indexed citations
19.
Adamson, David Cory, Qun Shi, Matthew Wortham, et al.. (2009). OTX2 Is Critical for the Maintenance and Progression of Shh-Independent Medulloblastomas. Cancer Research. 70(1). 181–191. 80 indexed citations
20.
Kongkham, Paul, Paul A. Northcott, Young Seob Shin, et al.. (2008). An Epigenetic Genome-Wide Screen Identifies SPINT2 as a Novel Tumor Suppressor Gene in Pediatric Medulloblastoma. Cancer Research. 68(23). 9945–9953. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026